Design of species- or isozyme-specific enzyme inhibitors. 2. Differences between a bacterial and a mammalian thymidine kinase in the effect of thymidine substituents on affinity for the thymidine site

Journal of Medicinal Chemistry
1979.0

Abstract

Derivatives obtained by monosubstitution at six positions of thymidine, 5'-amino-5'-deoxythymidine, or 5-bromo-5,6-dihydrothymidine have been studied as inhibitors of Escherichia coli and hamster thymidine kinases (TK). Affinity for the enzymatic thymidine binding sites was assessed from apparent enzyme-inhibitor dissociation constants (K, values; for inhibitions competitive with respect to thymidine at near-saturating ATP levels) or Is0 values (for noncompetitive inhibitions). To provide indices of relative affinity for each enzyme, the K, and 1% values were divided by the appropriate KM value (33 or 3.3 FM) of thymidine with the E. coli and hamster enzymes, respectively. 3-Amylthymidine gave I50/KM = 20 with E. coli and K,/KM = 21 with hamster TK; 5-amino-2'-deoxyuridine gave I50/KM = 840 with E. coli TK and KJKM = 135 with hamster TK; tr~ns-5-bromo-6-ethoxy-5,6-dihydrothymidine diastereoisomers at 16 mM showed almost no inhibition of E. coli TK and gave K, = 0.2-0.3 mM with hamster TK; 3'-acetamido- and 3'-(ethylthio)-3'-deoxythymidines gave IbO/KM = 183 and 9.6, respectively, with E. coli TK and K,/KM = 750 and 3.6, respectively, with hamster TK; 5'-C-(acetamidomethyl)- and 5'-C-(propionamidomethy1)thymidine epimers inhibited both enzymes competitively (KJKM = 26-198 for E. coli and 20-330 for hamster), and the extra methyl present in the propionamido derivatives produced 7.5- and 9-fold differential effects on binding; 5'-amino-5'-deoxythymidine also inhibited competitively (K,/KM = 9.6 for E. coli and 1.8 for hamster), and addition of a 5'-N-hexyl group reduced the differential affinity (KI/KM = 78 for E. coli and 54 for hamster); some 5'-(alkylthio)-5'-deoxythymidines inhibited hamster TK competitively but activated E. coli TK, possibly by interacting at its dCDP-dCTP activator site. The evidence indicates that thymidine derivatives suitably substituted at any one of the above six positions can bind to the thymidine sites of the E. coli and hamster thymidine kinases in a species-selective manner.

Knowledge Graph

Similar Paper

Design of species- or isozyme-specific enzyme inhibitors. 2. Differences between a bacterial and a mammalian thymidine kinase in the effect of thymidine substituents on affinity for the thymidine site
Journal of Medicinal Chemistry 1979.0
Species- or isozyme-specific enzyme inhibitors. 5. Differential effects of thymidine substituents on affinity for rat thymidine kinase isozymes
Journal of Medicinal Chemistry 1982.0
Design of species- or isozyme-specific enzyme inhibitors. I. Effect of thymidine substituents on affinity for the thymidine site of hamster cytoplasmic thymidine kinase
Journal of Medicinal Chemistry 1979.0
Design of species- or isozyme-specific enzyme inhibitors. 3. Species and isozymic differences between mammalian and bacterial adenylate kinases in substituent tolerance in an enzyme-substrate complex
Journal of Medicinal Chemistry 1979.0
Species- or isozyme-specific enzyme inhibitors. 7. Selective effects in inhibitions of rat adenylate kinase isozymes by adenosine 5'-phosphate derivatives
Journal of Medicinal Chemistry 1982.0
Species- and isozyme-specific enzyme inhibitors. 6. Synthesis and evaluation of two-substrate condensation products as inhibitors of hexokinases and thymidine kinases
Journal of Medicinal Chemistry 1982.0
N-Substituted Thymine Derivatives as Mitochondrial Thymidine Kinase (TK-2) Inhibitors
Journal of Medicinal Chemistry 2006.0
Species- or isozyme-specific enzyme inhibitors. 4. Design of a two-site inhibitor of adenylate kinase with isozyme selectivity
Journal of Medicinal Chemistry 1982.0
Species- or isozyme-specific enzyme inhibitors. 9. Selective effects in inhibitions of rat pyruvate kinase isozymes by adenosine 5'-diphosphate derivatives
Journal of Medicinal Chemistry 1982.0
Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases
Journal of Medicinal Chemistry 1982.0